We are live on
!
Find out more
Ensign Peak Advisors Portfolio holdings
AUM
$53.7B
1-Year Est. Return
29.47%
This Fund
S&P 500
This Quarter
Est. Return
-3.67%
1 Year Est. Return
+29.47%
3 Year Est. Return
+102.45%
5 Year Est. Return
+139.11%
10 Year Est. Return
–
AUM
$40.3B
AUM Growth
-$1.82B
(-4.3%)
Cap. Flow
+$332M
Cap. Flow
% of AUM
0.83%
Top 10 Holdings %
Top 10 Hldgs %
25.24%
Holding
2,393
New
237
Increased
785
Reduced
642
Closed
83
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mastercard
MA
|
+$231M |
| 2 |
Gilead Sciences
GILD
|
+$113M |
| 3 |
PG&E
PCG
|
+$102M |
| 4 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$80.2M |
| 5 |
Allstate
ALL
|
+$64.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$472M |
| 2 |
AbbVie
ABBV
|
+$121M |
| 3 |
iShares MSCI USA Value Factor ETF
VLUE
|
+$69.5M |
| 4 |
Salesforce
CRM
|
+$64.3M |
| 5 |
Home Depot
HD
|
+$62.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.24% |
| 2 | Healthcare | 19.03% |
| 3 | Financials | 13.02% |
| 4 | Consumer Discretionary | 9.39% |
| 5 | Industrials | 7.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DCT
1926
DELISTED
Duck Creek Technologies, Inc. Common Stock
DCT
| $176K | ﹤0.01% |
14,880
+3,530
| +31% | +$46.7K |
|
1927
Warby Parker
WRBY
$3.19B
| $175K | ﹤0.01% |
+13,100
| New | +$174K |
|
1928
Clear Secure
YOU
$5.43B
| $173K | ﹤0.01% |
7,580
+2,040
| +37% | +$50K |
|
1929
WIX.com
WIX
$2.45B
| $172K | ﹤0.01% |
2,200
-300
| -12% | -$20.7K |
|
1930
Alignment Healthcare
ALHC
$3.81B
| $170K | ﹤0.01% |
+14,360
| New | +$210K |
|
|
MNTV
1931
DELISTED
Momentive Global Inc. Common Stock
MNTV
| $170K | ﹤0.01% |
29,180
+5,250
| +22% | +$40.8K |
|
1932
Atea Pharmaceuticals
AVIR
$361M
| $169K | ﹤0.01% |
29,780
| – | – |
|
|
CMRC
1933
Commerce.com Inc Series 1
CMRC
$264M
| $169K | ﹤0.01% |
11,450
+3,230
| +39% | +$55.4K |
|
1934
Coupang
CPNG
$27.7B
| $169K | ﹤0.01% |
10,142
| – | – |
|
|
TSVT
1935
DELISTED
2seventy bio
TSVT
| $169K | ﹤0.01% |
11,633
+4,430
| +62% | +$65.8K |
|
1936
Kinross Gold
KGC
$28.1B
| $168K | ﹤0.01% |
40,821
-19,000
| -32% | -$64.6K |
|
1937
PureCycle Technologies
PCT
$1.24B
| $168K | ﹤0.01% |
20,790
| – | – |
|
1938
Rocket Companies
RKT
$39.6B
| $167K | ﹤0.01% |
26,400
| – | – |
|
1939
Revolve Group
RVLV
$1.92B
| $167K | ﹤0.01% |
7,720
| – | – |
|
1940
Artivion
AORT
$1.31B
| $166K | ﹤0.01% |
12,000
| – | – |
|
|
HSII
1941
DELISTED
Heidrick & Struggles
HSII
| $166K | ﹤0.01% |
6,400
| – | – |
|
1942
Core Laboratories
CLB
$493M
| $165K | ﹤0.01% |
12,266
-4,130
| -25% | -$69.6K |
|
1943
Recursion Pharmaceuticals
RXRX
$1.62B
| $165K | ﹤0.01% |
15,470
| – | – |
|
|
TBRG
1944
DELISTED
TruBridge
TBRG
| $165K | ﹤0.01% |
5,930
| – | – |
|
1945
MBIA
MBI
$278M
| $162K | ﹤0.01% |
17,620
+6,120
| +53% | +$72.6K |
|
|
RAPT
1946
DELISTED
RAPT Therapeutics
RAPT
| $162K | ﹤0.01% |
843
+242
| +40% | +$45.8K |
|
1947
SiriusPoint
SPNT
$3.09B
| $162K | ﹤0.01% |
32,660
+960
| +3% | +$4.46K |
|
1948
Target Hospitality
TH
$1.47B
| $162K | ﹤0.01% |
+12,830
| New | +$161K |
|
|
BIG
1949
DELISTED
Big Lots, Inc.
BIG
| $162K | ﹤0.01% |
10,351
-4,210
| -29% | -$90.6K |
|
1950
Skywest
SKYW
$4.51B
| $161K | ﹤0.01% |
9,892
| – | – |
|
Similar funds
SCP
Ensign Peak Advisors's Q3 2022 Portfolio in Review
As of Q3 2022, Ensign Peak Advisors held 2,393 positions worth $40.3B, down 4.3% from $42.1B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Ensign Peak Advisors's Q3 2022 filing shows 237 new, 785 increased, 642 reduced and 83 closed positions. Its largest new stake was iShares 1-3 Year Treasury Bond ETF: 975,000 shares worth $79.2M. The largest sale was Visa, an estimated $472M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Healthcare and Financials.
- Ensign Peak Advisors's largest Q3 2022 buy was iShares 1-3 Year Treasury Bond ETF: 975,000 shares worth $79.2M.
- Ensign Peak Advisors added most to Mastercard in Q3 2022, an estimated $231M increase.
- Ensign Peak Advisors's biggest Q3 2022 reduction was AbbVie, cutting an estimated $121M.
- Ensign Peak Advisors fully exited Visa in Q3 2022, selling an estimated $472M.
- Ensign Peak Advisors's ten largest holdings make up 25% of its $40.3B portfolio in Q3 2022.
- Ensign Peak Advisors opened 237 new positions and closed 83 in Q3 2022.
- Ensign Peak Advisors's portfolio value fell 4.3% quarter-over-quarter to $40.3B.
Based on Ensign Peak Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.